← Leaderboards
Edith A Perez
Mayo Clinic Coll Of Medicine, Rochester
$1,891,637
Attributed
$4,161,076
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.6M · FY2008–15$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$16,056,090 · 4
By mechanism
U10$12,052,754 · 2
R01$4,003,336 · 2
Top collaborators
- Monica M Bertagnolli6 shared
- Gini F Fleming6 shared
- Keith L Knutson5 shared
- Raphael A Clynes4 shared
- Monica Madden Reinholz3 shared
Most similar at Mayo Clinic Coll Of Medicine, Rochester
Same institution · by research overlap
- James R Cerhan$31,221,407
Others in their field
Top investigators on “Multidisciplinary”
- Lawrence Corey · Fred Hutchinson Cancer Center$298,997,339
- David Heimbrook · Leidos Biomedical Research, Inc.$251,484,793
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Gregory H Reaman · National Childhood Cancer Foundation$201,951,987
- Judith S. Currier · University Of California Los Angeles$188,628,043
- Barton F Haynes · Duke University$186,871,361
Research focus
MultidisciplinaryTumorResponseBaseClinical TrialsNorth Central Cancer Treatment GroupMalignant Breast NeoplasmCancer PatientInsightMalignant NeoplasmsCancer TherapyPathogenesisPatient CareMolecularDesignGenotypeEnrollmentBreastGeneticClinicClinical CareBiological MarkersAdjuvantHumanized Monoclonal Antibodies
Grant awards (18)
Alliance for Clinical Trials in Oncology Operations Center$810,357
U10 · FY2015 · CA
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$534,720
R01 · FY2015 · CA · contact PI
Alliance for Clinical Trials in Oncology Operations Center$34,176
U10 · FY2015 · CA
Alliance for Clinical Trials in Oncology Operations Center$10,540,919
U10 · FY2014 · CA
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$521,566
R01 · FY2014 · CA · contact PI
Alliance for Clinical Trials in Oncology Operations Center$264,661
U10 · FY2014 · CA
Alliance for Clinical Trials in Oncology Operations Center$228,063
U10 · FY2014 · CA
Alliance for Clinical Trials in Oncology Operations Center$16,838
U10 · FY2014 · CA
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$511,906
R01 · FY2013 · CA · contact PI
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$549,804
R01 · FY2012 · CA · contact PI
Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab$619,306
R01 · FY2011 · CA · contact PI
Predictive Biomarkers of Adjuvant Trastuzumab in the HER2+N9831 Intergroup Trial$198,652
R01 · FY2011 · CA · contact PI
Predictive Biomarkers of Adjuvant Trastuzumab in the HER2+N9831 Intergroup Trial$198,218
R01 · FY2010 · CA · contact PI
Predictive Biomarkers of Adjuvant Trastuzumab in the HER2+N9831 Intergroup Trial$483,070
R01 · FY2009 · CA · contact PI
Predictive Biomarkers of Adjuvant Trastuzumab in the HER2+N9831 Intergroup Trial$386,094
R01 · FY2008 · CA · contact PI
BREAST CANCER$78,870
U10 · FY2002 · CA
BREAST CANCER$78,870
U10 · FY2002 · CA
BREAST CANCER$0
U10 · FY2001 · CA